ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Astellas Pharma US 

1 Astellas Way

Northbrook  Illinois  60062  U.S.A.
Phone: 800-695-4321 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Astellas Pharma US Teams Up With USA Rugby And Men's Health Network To Encourage Chicagoans To Answer The Challenge For Better Health 10/15/2014 8:13:43 AM
Brian McLellan Promoted To President Of Astellas Pharma US 10/2/2014 8:46:16 AM
Astellas Pharma US Appoints Karl Uhlendorf As Communications And Advocacy Director 6/24/2014 8:21:23 AM
Astellas Pharma US Release: Enzalutamide Data, Including Additional Results From The PREVAIL Trial, To Be Presented At Upcoming American Society of Clinical Oncology Annual Meeting 5/15/2014 7:04:42 AM
Astellas Pharma US Promotes Jeffrey Bloss To SVP Of Medical Affairs For The Americas 4/16/2014 6:35:08 AM
Astellas Pharma US Announces European Regulatory Submission For XTANDI® (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer 4/3/2014 9:23:22 AM
Astellas Pharma US Secures Exclusive Rights To Commercialize Isavuconazole In The U.S. And Canada 2/28/2014 10:58:47 AM
Astellas Pharma US To Present At J.P. Morgan Healthcare Conference 1/7/2014 8:01:30 AM
Astellas Pharma US And Vical Incorporated (VICL) Announce Initiation Of Phase 2 Trial Of ASP0113, A Cytomegalovirus Vaccine, In Solid Organ Transplant Recipients 12/10/2013 11:07:28 AM
FDA Grants Astellas Pharma US Qualified Infectious Disease Product Designation For Isavuconazole For The Treatment Of Invasive Aspergillosis 12/3/2013 11:26:40 AM
12345678